Search results
Processors and Graphics Chips Q1 Earnings: Nvidia (NASDAQ:NVDA) Simply the Best
StockStory via Yahoo Finance UK· 10 hours agoAs the Q1 earnings season comes to a close, it’s time to take stock of this quarter's best and worst...
Q1 Earnings Highs And Lows: Magnachip (NYSE:MX) Vs The Rest Of The Analog Semiconductors Stocks
StockStory via Yahoo Finance UK· 10 hours agoLooking back on analog semiconductors stocks' Q1 earnings, we examine this quarter's best and worst...
Q1 Earnings Highs And Lows: Topgolf Callaway (NYSE:MODG) Vs The Rest Of The Leisure Facilities...
StockStory via Yahoo Finance UK· 10 hours agoThe end of the earnings season is always a good time to take a step back and see who shined (and who...
Defense Contractors Stocks Q1 Recap: Benchmarking Leidos (NYSE:LDOS)
StockStory via Yahoo Finance UK· 10 hours agoIt was a weak quarter for the company, with a miss of analysts' earnings estimates. Mercury Systems...
Inspection Instruments Stocks Q1 Recap: Benchmarking Keysight (NYSE:KEYS)
StockStory via Yahoo Finance UK· 10 hours agoThe end of the earnings season is always a good time to take a step back and see who shined (and who...
Unpacking Q1 Earnings: Floor And Decor (NYSE:FND) In The Context Of Other Home Furnishing and...
StockStory via Yahoo Finance UK· 10 hours agoWrapping up Q1 earnings, we look at the numbers and key takeaways for the home furnishing and...
Reflecting On Personal Care Stocks’ Q1 Earnings: Estée Lauder (NYSE:EL)
StockStory via Yahoo Finance UK· 10 hours agoIt was a weak quarter for the company, with revenue guidance for next quarter missing analysts'...
Reflecting On Perishable Food Stocks’ Q1 Earnings: Cal-Maine (NASDAQ:CALM)
StockStory via Yahoo Finance UK· 10 hours agoThe end of the earnings season is always a good time to take a step back and see who shined (and who...
Global Dietary Supplement Market Set to Reach USD 170.1 Billion by 2034 with a Steady CAGR of 9.5% |
PharmiWeb· 12 hours agoThe global dietary supplement market value is poised for significant growth, with projections indicating it will attain a valuation of approximately USD 170.1 billion by 2034. This represents ...
Mainz Biomed Provides Half Year 2024 Corporate Update
PharmiWeb· 12 hours agoMAINZ, Germany – July 2, 2024 — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments ...